4//SEC Filing
Hansen Paul R. 4
Accession 0001493152-21-007812
CIK 0001349929other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 9:27 PM ET
Size
9.2 KB
Accession
0001493152-21-007812
Insider Transaction Report
Form 4
Vyant Bio, Inc.VYNT
Hansen Paul R.
Director
Transactions
- Other
Common Stock, $0.0001 par value
2021-03-30+592,548→ 592,548 total - Other
Common Stock, $0.0001 par value
2021-03-30+65,000→ 65,000 total(indirect: By Trust) - Award
Stock option (right to buy)
2021-03-30+13,015→ 13,015 totalExercise: $4.61From: 2021-03-30Exp: 2031-03-30→ Common Stock (13,015 underlying)
Footnotes (1)
- [F1]Pursuant to that certain Agreement and Plan of Merger, dated as of August 21, 2020, as amended, by and among Cancer Genetics, Inc. now known as Vyant Bio, Inc. ("Issuer"), CGI Acquisition, Inc., a Minnesota corporation and a wholly-owned subsidiary of Issuer ("Merger Sub") and StemoniX, Inc., a Minnesota corporation ("StemoniX") (the "Merger Agreement"), Reporting Person received shares of the Issuer's common stock, $0.0001 par value (the "Common Stock") in exchange shares of StemoniX common stock, $0.0001 owned prior to the merger.
Documents
Issuer
Vyant Bio, Inc.
CIK 0001349929
Entity typeother
Related Parties
1- filerCIK 0001850324
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 9:27 PM ET
- Size
- 9.2 KB